St. Jude's struggling against rivals Medtronic and Boston Scientific in the neuromodulation space, but its latest approval of its Prodigy device should keep investors looking for more.
The synergistic acquisition of Arthrocare and a focus on higher-growth sports medicine and wound care markets offers some relative value.
Innovative medical device stocks Intuitive Surgical and Edwards Lifesciences have been hit hard over the past year, but is either stock an under-the-radar pick ready to bounce back?
3-D printing could revolutionize the medical devices industry and dramatically alter the future for medical device makers Hanger, Johnson & Johnson, Medtronic, and St. Jude.
Medtronic takes the victory in its latest battle with Edwards Lifesciences over heart valve patents.
Abbott Labs and Medtronic sport attractive dividends for long-term investors, but which health-care giant's the best stock for your financial future?
Johnson & Johnson, UnitedHealth, and Medtronic boast great dividends, steady cash flow, and solid potential that should tantalize any long-term dividend investor's eye.
JNJ's European approval for a renal denervation device was unexpected, but more work needs to be done.
Can Hologic Inc. turn itself around? Famous billionaire Carl Icahn thinks so. Icahn, with a large stake in the company, is pushing for better performance and a higher share price from the medical device maker. Should individual investors join in on his turnaround quest?
Clinical disappoints and more aggressive rivals have pushed this large med-tech into value territory.